{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute Lymphoblastic Leukemia (B-ALL)","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-2-study-of-inotuzumab-ozogamicin-nsc-772518-in-children-and-young-adults-with-relapsed-or-refractory-cd22-b-acute-lymphoblastic-leukemia-b-all\/#breadcrumbitem"}]}